May 19, 2020 / 7:05 AM / 11 days ago

BRIEF-Spago Nanomedical Updates On Preclinical Studies Of Tumorad

May 19 (Reuters) - Spago Nanomedical AB (publ):

* PRECLINICAL STUDIES SHOW TUMORAD ACCUMULATES IN TUMORS TO AN EXTENT WHICH MEANS SUBSTANCE HAS GOOD POTENTIAL TO BECOME CLINICALLY USEFUL Source text for Eikon: [ID:cisn.co/3bQtDNn] Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below